Tokyo Tape
Sign in
← CellSeed

Annual report

7776.TEDINET S100T4XQ
Period2023-01-01 → 2023-12-31
Filed2024-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 13 passed
Key figures · 100
MetricValuePeriodScopeSource row
Revenue¥190m2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥162m2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥199m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥276m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income−¥698m2023-01-01 → 2023-12-31StandaloneOperating income
Operating income−¥743m2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income−¥710m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥887m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥866m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥745m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥729m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥786m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥787m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥846m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax−¥759m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income (owners)−¥915m2021-01-01 → 2021-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥784m2020-01-01 → 2020-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥782m2019-01-01 → 2019-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥847m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥913m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income−¥768m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥783m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥2.5bnat 2023-12-31StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥301mat 2023-12-31StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥2.2bnat 2023-12-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.6bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.2bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥2.2bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥931mat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.5bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥779m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥718m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥817m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥701m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥578m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥56m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥62m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥110m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥133m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥882m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥397m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥721m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-29.432023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.182021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-55.312020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-54.192020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.62019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.682019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥68.08at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥47.26at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥56.44at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥57.43at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥93.85at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥95.7at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥102.24at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥103.88at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio86.9%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.1%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued31,459,019at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued16,008,319at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued12,981,819at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees35at 2023-12-31StandaloneNumber of employees
Employees30at 2022-12-31StandaloneNumber of employees
Employees44at 2021-12-31dStandaloneNumber of employees
Employees40at 2020-12-31dStandaloneNumber of employees
Employees40at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 40
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2023-01-01 → 2023-12-31¥21m
Reconciling Itemsreconcilingsegment assetsat 2023-12-31¥2.3bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥197m
Cell Sheet Regenerative Medicinereportable segmentemployeesat 2023-12-3120 pure
Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-12-31¥8m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-12-31¥8m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2023-12-31¥65m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-12-31−¥469m
Laboratory Consumables And Equipmentreportable segmentcapex2023-01-01 → 2023-12-31¥770,000
Laboratory Consumables And Equipmentreportable segmentdepreciation2023-01-01 → 2023-12-31¥8m
Laboratory Consumables And Equipmentreportable segmentemployeesat 2023-12-3110 pure
Laboratory Consumables And Equipmentreportable segmentrevenue2023-01-01 → 2023-12-31¥182m
Laboratory Consumables And Equipmentreportable segmentrevenue external2023-01-01 → 2023-12-31¥182m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2023-12-31¥133m
Laboratory Consumables And Equipmentreportable segmentsegment profit2023-01-01 → 2023-12-31−¥32m
—segment totalcapex2023-01-01 → 2023-12-31¥770,000
—segment totaldepreciation2023-01-01 → 2023-12-31¥8m
—segment totalrevenue2023-01-01 → 2023-12-31¥190m
—segment totalrevenue external2023-01-01 → 2023-12-31¥190m
—segment totalsegment assetsat 2023-12-31¥198m
—segment totalsegment profit2023-01-01 → 2023-12-31−¥501m
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥3m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥190m
Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2022-12-31¥82m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-12-31−¥463m
Laboratory Consumables And Equipmentreportable segmentcapex2022-01-01 → 2022-12-31¥563,000
Laboratory Consumables And Equipmentreportable segmentdepreciation2022-01-01 → 2022-12-31¥8m
Laboratory Consumables And Equipmentreportable segmentrevenue2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentrevenue external2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2022-12-31¥196m
Laboratory Consumables And Equipmentreportable segmentsegment profit2022-01-01 → 2022-12-31−¥90m
—segment totalcapex2022-01-01 → 2022-12-31¥563,000
—segment totaldepreciation2022-01-01 → 2022-12-31¥8m
—segment totalrevenue2022-01-01 → 2022-12-31¥126m
—segment totalrevenue external2022-01-01 → 2022-12-31¥126m
—segment totalsegment assetsat 2022-12-31¥277m
—segment totalsegment profit2022-01-01 → 2022-12-31−¥553m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 992
ItemContextValueUnit
Interest income noiPrior1YearDuration_NonConsolidatedMember10000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember13000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember1531000JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember－JPY
Commission fee noiPrior1YearDuration_NonConsolidatedMember193000JPY
Commission fee noiCurrentYearDuration_NonConsolidatedMember109000JPY
Interest on refund noiPrior1YearDuration_NonConsolidatedMember12000JPY
Interest on refund noiCurrentYearDuration_NonConsolidatedMember59000JPY
Income from fees for business noiPrior1YearDuration_NonConsolidatedMember－JPY
Income from fees for business noiCurrentYearDuration_NonConsolidatedMember400000JPY
Other noiPrior1YearDuration_NonConsolidatedMember63000JPY
Other noiCurrentYearDuration_NonConsolidatedMember11000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember1811000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember593000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember835000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember1128000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember－JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember46000JPY
Stock issuance cost prior noePrior1YearDuration_NonConsolidatedMember12034000JPY
Stock issuance cost prior noeCurrentYearDuration_NonConsolidatedMember11918000JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember12869000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember13093000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-754274000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-710276000JPY
Gain on reversal of subscription rights to shares eiPrior1YearDuration_NonConsolidatedMember2502000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration_NonConsolidatedMember912000JPY
Gain on sales of subsidiaries and affiliates stocks eiPrior1YearDuration_NonConsolidatedMember－JPY
Gain on sales of subsidiaries and affiliates stocks eiCurrentYearDuration_NonConsolidatedMember15759000JPY
Extraordinary incomePrior1YearDuration_NonConsolidatedMember2502000JPY
Extraordinary incomeCurrentYearDuration_NonConsolidatedMember16671000JPY
Impairment loss elPrior1YearDuration_NonConsolidatedMember3490000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember112028000JPY
Loss on valuation of investment securities elPrior1YearDuration_NonConsolidatedMember－JPY
Loss on valuation of investment securities elCurrentYearDuration_NonConsolidatedMember39950000JPY
Loss on liquidation of subsidiaries and affiliates elPrior1YearDuration_NonConsolidatedMember3467000JPY
Loss on liquidation of subsidiaries and affiliates elCurrentYearDuration_NonConsolidatedMember－JPY
Extraordinary lossPrior1YearDuration_NonConsolidatedMember6958000JPY
Extraordinary lossCurrentYearDuration_NonConsolidatedMember151979000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember-758730000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember-845584000JPY
Income taxes currentPrior1YearDuration_NonConsolidatedMember950000JPY
Income taxes currentCurrentYearDuration_NonConsolidatedMember950000JPY
Income taxesPrior1YearDuration_NonConsolidatedMember950000JPY
Income taxesCurrentYearDuration_NonConsolidatedMember950000JPY
Profit lossPrior1YearDuration_NonConsolidatedMember-759680000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-846534000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalStockMember4548657000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_LegalCapitalSurplusMember1770454000JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_OtherCapitalSurplusMember－JPY
Net assetsPrior2YearInstant_NonConsolidatedMember_CapitalSurplusMember1770454000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31mismatch
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass